Ignite Planners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,227
Closed -$265K 427
2026
Q1
$265K Buy
4,227
+249
+6% +$19.9K 0.04% 340
2025
Q4
$372K Buy
3,978
+361
+10% +$35.4K 0.06% 293
2025
Q3
$353K Buy
3,617
+146
+4% +$15.1K 0.06% 270
2025
Q2
$360K Sell
3,471
-434
-11% -$43.9K 0.06% 258
2025
Q1
$403K Buy
3,905
+142
+4% +$14.3K 0.08% 231
2024
Q4
$341K Buy
3,763
+33
+0.9% +$2.9K 0.07% 219
2024
Q3
$313K Buy
3,730
+35
+0.9% +$2.76K 0.07% 225
2024
Q2
$282K Buy
3,695
+458
+14% +$33.5K 0.07% 225
2024
Q1
$220K Buy
+3,237
New +$208K 0.06% 260

Other funds holding BSX

Ignite Planners's BSX Position: Q2 2026 in Review

Ignite Planners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,227 shares — an estimated $265K sold.

Ignite Planners first reported a position in BSX in Q1 2024 and held it in 9 quarters. The position peaked at $403K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ignite Planners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Ignite Planners sold 4,227 Boston Scientific shares in Q2 2026, an estimated $265K.
  • Ignite Planners first reported a position in Boston Scientific in Q1 2024 and held it in 9 quarters.
  • Ignite Planners's Boston Scientific position peaked at $403K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.